Abstract
Radiation-induced oral mucositis (RIOM) is a common side effect after radiotherapy (RT) in head and neck cancer (HNC) patients. RIOM patients with severe pain have difficulty in eating, which increases the incidence of malnutrition and affects patients' quality of life and the process of RT. The mechanism of RIOM is not fully understood, and inflammatory response and oxidative stress appear to be important for RIOM occurrence and development. The nutritional status of patients is very important for their RT tolerance and recovery. Malnutrition, which can lead to anemia, low protein, decreased immunity and other problems, is an important clinical factor affecting tumor progression and treatment. Recent studies have shown that early nutritional intervention can ameliorate oral mucositis and nutritional status of patients with HNC. However, in clinical practice, early nutritional intervention for patients with HNC is not a conventional intervention strategy. Therefore, this review summarized the possible pathogenesis of RIOM, commonly used assessment tools for malnutrition in patients, and recent studies on the effects of early nutritional interventions on RIOM and nutritional status of patients with HNC. We hope to provide the basis and reference for the clinical application of early nutritional intervention models.
Introduction
Radiotherapy (RT) is a cornerstone of treatment for head and neck cancer (HNC). However, its therapeutic benefits are often accompanied by significant toxicity, most notably radiation-induced oral mucositis (RIOM). RIOM is characterized by painful inflammation and ulceration of the oral mucosa, which can severely impair a patient's ability to eat and drink. This leads to a rapid decline in nutritional status, creating a "vicious cycle" where malnutrition delays mucosal healing, further exacerbating pain and reducing intake.
Malnutrition in HNC patients is not merely a side effect but a critical clinical hurdle. It can lead to systemic issues such as anemia, hypoalbuminemia, and impaired immune function. Furthermore, significant weight loss can alter a patient's physical dimensions, causing radiotherapy masks to fit improperly and potentially compromising the precision of radiation delivery. Historically, nutritional support has been reactive, initiated only after significant weight loss or severe symptoms occur. This review advocates for a proactive shift toward early nutritional intervention (ENI).
Pathogenesis of RIOM
The development of RIOM is a complex biological process traditionally described in five overlapping stages: initiation, signaling, amplification, ulceration, and healing. The primary drivers are reactive oxygen species (ROS) generated by radiation, which damage DNA and activate key signaling pathways.
The "amplification" stage is particularly critical. Activation of the NF-κB pathway leads to the production of pro-inflammatory cytokines, including TNF-α, IL-1, and IL-6. This "cytokine storm" creates a feedback loop that intensifies tissue damage, leading to the painful, confluent ulcers characteristic of severe RIOM. Understanding these mechanisms highlights why early intervention—targeting the inflammatory environment before it reaches peak intensity—is theoretically sound.
Nutritional Assessment and Intervention Strategies
Identifying patients at high risk for malnutrition is essential for the success of ENI. Several validated tools are used in clinical practice:
- NRS2002 (Nutritional Risk Screening): A quick tool assessing disease severity and nutritional status.
- MUST (Malnutrition Universal Screening Tool): Focuses on BMI and weight loss.
- MNA (Mini Nutrition Assessment): Often used for elderly populations.
- PG-SGA (Patient-Generated Subjective Global Assessment): Widely considered the gold standard for oncology patients, as it incorporates symptoms like pain and "eating fear."
Early nutritional intervention (ENI) typically begins before or at the very start of RT. Methods range from intensive oral nutritional supplements to enteral nutrition via nasogastric tubes or gastrostomy, depending on the patient's risk profile and the anticipated severity of treatment.
Clinical Evidence for Early Nutritional Intervention
A synthesis of recent clinical trials demonstrates that ENI significantly improves both nutritional and oncological outcomes compared to standard reactive care (Control Group, CG).
Key findings from these studies include:
- Reduced Severity of RIOM: ENI significantly lowers the incidence of Grade 3 and 4 mucositis. For instance, Wei et al. (2020) reported a reduction from 50.0% in the control group to 17.9% in the ENI group.
- Weight and Protein Preservation: Patients receiving ENI experience significantly less weight loss and better maintenance of serum albumin levels.
- Treatment Continuity: ENI reduces the frequency and duration of radiotherapy interruptions caused by toxicity. Meng et al. (2019) found that RT breaks were reduced from 25.0% to 10.9% with early intervention.
- Healthcare Utilization: Proactive support leads to fewer unplanned hospitalizations for dehydration or malnutrition-related complications.
Conclusion and Future Directions
Early nutritional intervention represents a paradigm shift in the supportive care of HNC patients undergoing radiotherapy. By addressing nutritional needs before the onset of severe RIOM, clinicians can break the cycle of pain and depletion, leading to better treatment tolerance and improved quality of life.
Despite the clear benefits, challenges remain. There is a lack of universal consensus on the exact timing and optimal delivery method for ENI. Future research should focus on large-scale, multi-center randomized controlled trials to standardize ENI protocols and integrate them into routine clinical practice for all head and neck cancer patients.
Summary updated